Suivi thérapeutique des médicaments (I). Les principes [Principles of therapeutic drug monitoring]


Autoria(s): Widmer N.; Csajka C.; Werner D.; Grouzmann E.; Decosterd L.A.; Eap C.B.; Biollaz J.; Buclin T.
Data(s)

2008

Resumo

Requesting a blood level measurement of a drug is part of the global approach known as "Therapeutic Drug Monitoring". Diverse situations require this monitoring approach, such as inadequate response to treatment or organ failure. Every drug however does not possess all the characteristics for a TDM program. The therapeutic range of a TDM drug has indeed to be narrow and its interindividual pharmacokinetic variability to be wide. As the development of new drugs is currently slowing down, the precise management of existing treatments certainly deserves progress, but needs however to be applied rationally, starting from a valid indication to blood sampling, and ending with a sound dosage adaptation decision.

Identificador

http://serval.unil.ch/?id=serval:BIB_56FB6F49D00F

isbn:1660-9379

pmid:18767290

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 4, no. 165, pp. 1644-1668

Palavras-Chave #Anti-Bacterial Agents; Anti-Retroviral Agents; Anticonvulsants; Antineoplastic Agents; Antiparasitic Agents; Antitubercular Agents; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Immunosuppressive Agents; Pharmaceutical Preparations; Product Surveillance, Postmarketing; Psychotropic Drugs
Tipo

info:eu-repo/semantics/review

article